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Background: Annona muricata leaves have been reported to have antiproliferative effects against various cancer
cell lines. However, the detailed mechanism has yet to be defined. The current study was designed to evaluate the
molecular mechanisms of A. muricata leaves ethyl acetate extract (AMEAE) against lung cancer A549 cells.
Methods: The effect of AMEAE on cell proliferation of different cell lines was analyzed by MTT assay. High content
screening (HCS) was applied to investigate the suppression of NF-κB translocation, cell membrane permeability,
mitochondrial membrane potential (MMP) and cytochrome c translocation from mitochondria to cytosol. Reactive
oxygen species (ROS) formation, lactate dehydrogenase (LDH) release and activation of caspase-3/7, −8 and −9 were
measured while treatment. The western blot analysis also carried out to determine the protein expression of cleaved
caspase-3 and −9. Flow cytometry analysis was used to determine the cell cycle distribution and phosphatidylserine
externalization. Quantitative PCR analysis was performed to measure the gene expression of Bax and Bcl-2 proteins.
Results: Cell viability analysis revealed the selective cytotoxic effect of AMEAE towards lung cancer cells, A549, with an
IC50 value of 5.09 ± 0.41 μg/mL after 72 h of treatment. Significant LDH leakage and phosphatidylserine externalization
were observed in AMEAE treated cells by fluorescence analysis. Treatment of A549 cells with AMEAE significantly
elevated ROS formation, followed by attenuation of MMP via upregulation of Bax and downregulation of Bcl-2,
accompanied by cytochrome c release to the cytosol. The incubation of A549 cells with superoxide dismutase and
catalase significantly attenuated the cytotoxicity caused by AMEAE, indicating that intracellular ROS plays a pivotal role
in cell death. The released cytochrome c triggered the activation of caspase-9 followed by caspase-3. In addition,
AMEAE-induced apoptosis was accompanied by cell cycle arrest at G0/G1 phase. Moreover, AMEAE suppressed the
induced translocation of NF-κB from cytoplasm to nucleus.
Conclusions: Our data showed for the first time that the ethyl acetate extract of Annona muricata inhibited the
proliferation of A549 cells, leading to cell cycle arrest and programmed cell death through activation of the
mitochondrial-mediated signaling pathway with the involvement of the NF-kB signalling pathway.
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Lung cancer as one of the critical causes of cancer death
throughout the world has the prevalent complication of
apoptosis resistance against different anticancer agents
[1]. Due to the typical asymptomatic progression of lung
cancer at an early stage, it is normally diagnosed at an
advanced stage (56%). In spite of all the development in
chemoradiation and surgical techniques, the 5-year sur-
vival rate for patients with advanced stage disease is still
3.6% [2]. In addition, numerous lung cancer survivors
suffer from lung dysfunction, particularly patients with
the lung surgical history [3]. Thereby, continued re-
search into the development of safe and efficient new
anticancer agents against lung cancer cells is urgently
necessary for further improvements in cancer therapy.
Apoptosis is a critical physiological process responsible
for the homeostatic mechanism and maintenance of cell
populations in tissues [4]. Due to the close correlation
between the mechanism of apoptosis and the effect of
anticancer agents, extensive research has been done on
this mode of cell death [5]. The accumulation of reactive
oxygen species (ROS) in cancer cells is a critical factor
for the induction of apoptosis by natural products [6,7],
since it will result in oxidative DNA damage following
by a collapse in mitochondrial membrane potential
(MMP) and leakage of cytochrome c, which lead to the
activation of the caspase cascade [8]. Furthermore, the
perturbation in the expression level of Bax and Blc-2
proteins is an important factor to determine the suscep-
tibility of tumor cells to anticancer agents [9]. Previous
anticancer studies also proved that constitutive activa-
tion of the ubiquitous transcription factor of NF-κB
(nuclear factor-kappa B) is involved in governing the
promoting tumor progression of solid and hemopoietic
malignancies [10,11]. Therefore, anticancer agents with
the ability to suppress the NF-κB translocation are ef-
fectively induce the apoptosis in cancer cells.
Annona muricata L. known as gravel, guanabana and
soursop is a member of Custard-Apple plants in the
Annonaceae family due to a custard-like texture of its
fruit. It is a small deciduous tree with a height of 5–8 m
and roundish canopy [12]. This popular fruit tree has
been widely cultivated in many tropical countries and
traditionally used for an array of diseases and ailments
[13]. Previous studies demonstrated a significant cyto-
toxicity for A. muricata leaves against various cancer cell
lines without affecting the normal cells [14,15]. Due to
this tremendous antiproliferative effect, A. muricata was
described as “the cancer killer” [15]. Ethanolic extract of
A. muricata leaves was suggested to have apoptosis-
inducing potential against myelogenous leukemic K562
cells, although the detailed mechanism of action has not
been explained [16]. Amongst constituents isolated from
A. muricata leaves, namely annonaceous acetogenins,alkaloids and essential oils, annonaceous acetogenins are
strongly implied to be responsible for the promising an-
ticancer effect [17]. The principle objective of this study
was to examine how A. muricata leaves affecting A549
lung cancer cells, and to investigate the possible mech-
anism of action involved in this effect.
Methods
Plant material and extraction procedures
The plant species (Annona muricata) collected from
Ipoh, Malaysia, was authenticated by Dr. Yong Kien
Thai, an ethnobotanist from the department of Bio-
logical Sciences, University of Malaya. The voucher spe-
cimen number for this plant is KLU47978. The air-dried
leaves of A. muricata (1 kg) were cut into fine pieces
using a mill grinder and soaked in n-hexane (1500 mL,
three times) in conical flasks for four days at room
temperature (25–27°C). The n-hexane extract was fil-
tered and the residues were sequentially re-extracted
with ethyl acetate (1500 ml, three times) and methanol
(1500 ml, three times) using the same method. The result-
ant filtrate was concentrated to dryness by a Buchi R110
Rotavapor (Buchi Labortechnik AG, Flawil, Switzerland)
at 40°C and stored at – 30°C until use. The isolated ex-
tracts were dissolved in dimethyl sulfoxide (DMSO) for
further experiments.
Cell culture and MTT assay
MCF-7 (human breast cancer cells), MDA-MB-231
(human breast cancer cells), A549 (human lung cancer
cells), HepG2 (human hepatoma cells) and WRL-68 (human
hepatic cells) cell lines were obtained from American
Type Cell Collection (ATCC, Manassas, VA, USA).
Cells were cultured in RPMI-1640 medium (Sigma, St.
Louis, MO, USA) supplemented with 10% FBS (PAA,
Pasching, Austria), 100 U/mL penicillin (PAA) and
50 μg/mL amphotericin B (PAA) at 37°C with 5% CO2.
The negative control for all the assays was represented by
the untreated medium containing vehicle DMSO (0.1%).
The cytotoxicity of the extracts was determined using
the MTT assay as originally described by Mossman [18].
Briefly, cells were treated with different concentrations
(1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μg/mL) of three
isolated extracts (hexane, ethyl acetate and methanol)
and curcumin (positive control) in 96-well plates and in-
cubated for 72 h. After the incubation time, MTT dye
(20 μL, 5 mg/mL, Sigma) was added to the cells for 4 h
followed by incubation with DMSO for 10 min. The
colorimetric assay was measured at the absorbance of
570 nm using a microplate reader (Asys UVM340,
Eugendorf, Austria). The antiproliferative potential of
the extracts was expressed as IC50 values. As an ethyl
acetate extract of the leaves (AMEAE) demonstrated
the lowest IC50 value against lung cancer A549 cells,
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A549 cells.
LDH release assay
To confirm the cytotoxicity of AMEAE, we carried out lac-
tate dehydrogenase (LDH) release assay using Pierce™ LDH
Cytotoxicity Assay Kit (Thermo Scientific™, Pittsburgh, PA,
USA). In brief, A549 cells were treated with AMEAE at dif-
ferent concentrations for 48 h. The supernatant of treated
A549 cells was transferred into 96-well plate to assess the
LDH activity. Triton X-100 (2%) served as a positive con-
trol was used to completely lyse the cells and release
the maximum LDH. Next, the LDH reaction solution
(100 μl) was added to the cells for 30 min. The red color
intensity presenting the LDH activity was measured by the
absorbance at 490 using a Tecan Infinite®200 Pro (Tecan,
Männedorf, Switzerland) microplate reader. The level of
released LDH from treated cells was expressed as a per-
centage of positive control.
Acridine orange/propidium iodide (AO/PI) double staining
assay
Morphological changes induced by AMEAE in A549
cells were analyzed using Acridine orange/Propidium
iodide (AO/PI) double staining assay. Briefly, A549 cells
were seeded in 60 mm2 culture dishes followed by treat-
ment with AMEAE (10 μg/mL) for 24, 48 and 72 h. After
the incubation time, extract-untreated and treated A549
cells were harvested and washed with PBS. Then, the pel-
lets were stained with 10 μg/mL of AO/PI (1 mg/mL).
The stained cells were then observed under a BX51 UV-
fluorescent microscope (Olympus, Tokyo, Japan) within
30 min.
Annexin-V-FITC assay
Induction of the early and late apoptosis by AMEAE was
further studied via Annexin-V/PI staining assay. Briefly,
A549 cells (1 × 106) were plated in 60 mm2 culture dishes
and treated with vehicle DMSO and AMEAE (10 μg/mL)
for 24, 48 and 72 h. After harvest of adherent and suspen-
sion cells and washing them twice with PBS, they were re-
suspended in Annexin-V binding buffer (BD Biosciences,
San Jose, CA, USA) and stained with Annexin-V-FITC
(BD) and PI (Sigma) according to the manufacturer’s in-
structions. The fluorescence intensity of A549 cells was
then analyzed by flow cytometry (BD FACSCanto™ II, San
Jose, CA, USA) through quadrant statistics for necrotic
and apoptotic cell populations. PI was used for detection of
the late apoptosis and necrosis while Annexin-V was con-
sumed for the detection of the early and late apoptosis.
Cell cycle assay
A flow cytometry analysis was carried out to determine
the cell cycle distribution in treated A549 cells withAMEAE. In brief, A549 cells (5 × 104 cells/mL) were
treated with AMEAE (10 μg/mL) for 24, 48 and 72 h.
After fixation with cold ethanol, cells were washed with
PBS and stained with PI (50 μl, 10 mg/mL) for 1 h at 37°C.
In addition, RNase A (10 mg/mL) was also used to limit
the ability of the PI to bind only to DNA molecules. The
stained cells were analyzed for DNA content using flow
cytometer (BD FACSCanto™ II).
Reactive oxygen species (ROS) assay
The effect of AMEAE on the ROS formation in A549
cells was determined by ROS assay. Briefly, treated lung
cancer cells with AMEAE at different concentrations in
96-well plates were incubated for 24 h. After the incuba-
tion time, the treated cells were stained with dihy-
droethidium (DEH) at 2.5 μg/mL and Hoechst 33342
(500 nM) dyes for 30 min. Then, cells were fixed with
paraformaldehyde (3.5%) for 15 min and washed with PBS
twice. The Cellomics ArrayScan HCS reader was used to
measure the ROS generation in treated A549 cells.
To further determine the role of ROS generation in
AMEAE-induced antiproliferative effect, A549 cells were
treated with antioxidants prior to treatment with
AMEAE and the cell viability was measured after 24 h.
In brief, A549 cells in the exponential phase of growth
were supplemented with antioxidants superoxide dis-
mutase (SOD, 300 U/mL) and catalase (400 U/mL) for
1 h prior to AMEAE (20 μg/mL) treatment for 24 h.
After incubation time, the cell viability analysis was car-
ried out using a microplate reader (Asys UVM340,
Eugendorf, Austria).
Multiple cytotoxicity assay
To simultaneously determine the crucial apoptotic
events in A549 cells after treatment with AMEAE, we used
Cellomics Multiparameter Cytotoxicity 3 Kit (Thermo
Scientific™, Pittsburgh, PA, USA). Briefly, lung cancer
A549 cells were seeded into 96-well plates for 24 h.
The cells were treated with AMEAE at different con-
centrations prior to staining the cells with cell perme-
ability and mitochondrial membrane potential (MMP)
dyes. Then, cells were fixed and blocked with 1X blocking
buffer according to the manufacture’s protocol. Next, pri-
mary cytochrome c antibody and secondary DyLight 649
conjugated goat antimouse IgG were added for 1 h. Nuclei
of treated cells were also stained with Hoechst 33342 dye.
Stained A549 cells in 96-well plates were analyzed using
ArrayScan high content screening (HCS) system.
Bioluminescent assays for caspase-8, −9 and −3/7
activities
A dose-dependent study on the caspase-8, −9 and −3/7
activation was carried out using Caspase-Glo® 3/7, 8 and
9 kit (Promega, Madison, WI, USA). In brief, a total of
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well microplate and incubated with different concentra-
tions of AMEAE for 24 h. Then, caspase-Glo reagent
(100 μl) was added to the cells for 30 min. The induced
activation of caspases was measured using a Tecan Infin-
ite®200 Pro (Tecan, Männedorf, Switzerland) microplate
reader.
To determine the protein expression of cleaved caspase-
3 and −9, western blot analysis was carried out as previ-
ously described in detail [19]. In brief, A549 cells treated
with vehicle DMSO or AMEAE at different concentra-
tions were washed with PBS and lysed in ice-cold Radio
Immuno Precipitation Assay (RIPA) buffer. Cell extracts
(80 μg protein) were subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), trans-
ferred to nitrocellulose membrane, probed with anti-
β-actin, anti-cleaved caspase-9 and anti-cleaved caspase-3
(Cell Signaling Technology, Danvers, MA, USA). HRP-
conjugated secondary antibodies were used followed by
the detection of protein expression using the ECL plus
chemiluminescence kit (Amersham Biosciences, Piscat-
away, NJ, USA).Quantitative PCR analysis
The expression of the Bax and Bcl-2 in treated A549 cells
was analyzed by quantitative PCR analysis. After treatment
of A549 cells with the AMEAE extract at different concen-
trations for 24 h, Zymo Research Quick-RNA™ MiniPrep
kit (Zymo Research, Freiburg, Germany) was used to iso-
late total RNAs according to the manufacture’s protocol.
Then, High Capacity RNA-to-cDNA™ kit (Applied Biosys-
tems, Foster City, CA, USA) was used to synthesize
complementary DNAs. Quantitative PCR was carried
out with TaqMan® Gene Expression Assays and Taq-
Man® Fast Advanced Master Mix using the Applied Biosys-
tems StepOnePlus™ system. GAPDH was used to normalize
all data. The IDs for TaqMan® Gene Expression Assays
used in this study are GAPDH: Hs02758991_g1, Bcl-2:
Hs00608023_m1 and Bax: Hs00180269_m1.Measurement of NF-κB activity
The Cellomics ArrayScan HCS system was used to
analyze the suppressive effect of AMEAE on the nuclear
translocation of NF-κB induced by TNF-α. The experi-
ment was carried out using Cellomics nucleus factor-κB
(NF-κB) activation kit (Thermo Scientific) as previously
described [20]. In brief, A549 cells (1.0 × 104 cells/well)
were treated with AMEAE at different concentrations in
a 96-well plate for 3 h. The treated A549 cells were stim-
ulated by TNF-α (1 ng/mL) for 30 min. Then, cells were
fixed and stained according to the manufacturer’s protocol
and analyzed using Array Scan HCS Reader and Cyto-
plasm to Nucleus Translocation Bioapplication software.Statistical analysis
Data are presented as mean ± SEM of three individual
experiments. Statistical analysis was performed with a
one-way ANOVA analysis using the Prism statistical
software package (GraphPad Software, USA). Differences
were considered as being significant at *p < 0.05.
Results and discussion
AMEAE inhibited the proliferation of cancer cells
We first examined the cytotoxic effect of three extracts
(hexane, ethyl acetate and methanol) against MCF-7
(human breast cancer cells), MDA-MB-231 (human
breast cancer cells), A549 (human lung cancer cells),
HepG2 (human hepatoma cells) and WRL-68 (human
hepatic cells) cell lines by using MTT assay. Treatment
with AMEAE for 72 h significantly reduced the cell pro-
liferation in cancer cells. As shown in Table 1, the results
showed the significant cytotoxic activity of ethyl acetate
extract towards all cancer cells. The ethyl acetate extract
(IC50 ranged from 5.09 ± 0.41 to 11.36 ± 0.67 μg/mL)
showed the highest cytotoxicity against all cancer cells
as compared to others. Furthermore, the ethyl acetate
extract exhibited the highest cytotoxic activity towards
A549 cells with the IC50 of 5.09 ± 0.41 compared to
11.32 ± 1.54 for the positive control curcumin. After 24
and 48 h treatment with AMEAE, A549 cells elicited the
IC50 values of 17.542 ± 0.92 and 10.612 ± 1.34 μg/mL. It
is worth noting that normal human hepatic WRL-68
cells were not noticeably affected by AMEAE treatment.
The cell viability results suggested that the AMEAE in-
hibitory effect is selective for cancer cells.
Induction of LDH release by AMEAE
A stable cytosolic enzyme of lactate dehydrogenase (LDH)
catalyzes the oxidation of L-lactate to pyruvate. Upon
membrane damage in cells, LDH enzyme is released into
the culture medium, suggesting the loss of membrane in-
tegrity [21]. Therefore, to further confirm the cytotoxic ef-
fect of AMEAE on A549 cells, LDH assay was also
performed as another indicator of A549 cytotoxicity. As
shown in Figure 1, LDH leakage of A549 cells was signifi-
cantly increased with the presence of AMEAE by 5.9
folds.
Quantification of apoptosis using fluorescence
microscope and AO/PI double-staining
Energy-dependent biochemical pathways and distinct
morphological features are the main characteristics of
apoptosis, or programmed cell death. During the early
apoptosis, pyknosis and cell shrinkage are characterized
in apoptotic cells [22]. Cell shrinkage is a result of con-
densation of organelles and the density of cytoplasm,
and chromatin condensation or pyknosis is the most
critical feature of early apoptosis [23]. The process of
Table 1 IC50 values of A. muricata leaves extracts on five different cell lines after 72 h treatment
Extract IC50 (μg/mL)
MCF-7 MDA-MB-231 A549 HepG2 WRL-68
Hexane 49.92 ± 2.23 38.72 ± 0.99 21.05 ± 0.42 77.92 ± 2.23 89.53 ± 3.93
Ethyl acetate 6.39 ± 0.43 11.36 ± 0.67 5.09 ± 0.41 9.3 ± 0.91 47.10 ± 1.23
Methanol 85.58 ± 3.55 > 100 * > 100 > 100 > 100
Curcumin 7.65 ± 0.55 9.34 ± 0.76 11.32 ± 1.54 17.66 ± 1.21 54.24 ± 2.21
The data represent the means ± SEM of three independent experiments.
* > 100 represents the IC50 values greater than 100 μg/mL.
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extensive blebbing of plasma membrane with tightly
packed organelles [24]. In the present study, AMEAE was
examined for its apoptotic-inducing activity by fluores-
cence microscopy analysis. Morphological changes in con-
trol and treated A549 cells were observed after treatment
with AMEAE at 24, 48 and 72 h. It is noteworthy that
at 72 h the control cells remained intact and displayed
normal structures with a green intact nuclear structure
(Figure 2A). After 24 h of treatment, clear signs of
apoptosis, such as cytoplasmic shrinkage and mem-
brane blebbing, were observed at a treatment concen-
tration of 10 μg/mL. The early apoptotic cells wereFigure 1 Lactate dehydrogenase (LDH) assay showed the
cytotoxicity of AMEAE against A549 cells. The result revealed
significant cytotoxicity at concentrations of 5 to 40 μg/mL, in a
dose-dependent manner. The data represent the means ± SEM of
three independent experiments. *p < 0.05 compared with the
untreated group.detected via the binding of AO within the fragmented
DNA emanating a bright green fluorescence. At 24 h
treatment with AMEAE, moderate apoptosis was seen by
nuclear chromatin condensation and blebbing (Figure 2B).
In addition, the late stages of apoptosis as indicated by
changes such as the presence of a reddish-orange color
because of the binding of PI to denatured DNA were ob-
served after 48 and 72 h of treatment (Figure 2C and D).
The results showed that AMEAE generated morpho-
logical features that are associated with apoptosis in a
time-dependent manner.Induction of early and late apoptosis using flow
cytometry analysis
Our investigations thus far revealed the typical morpho-
logical features of apoptosis in AMEAE-treated A549
cells. The morphological changes in apoptotic cells are
accompanied by several biochemical modifications, in-
cluding DNA breakdown, protein cross-linking and pro-
tein cleavage which lead to the phagocytic recognition of
apoptotic cells by adjacent cells [25]. One such biochemical
modification is the expression of cell surface markers such
as inward-facing phosphatidylserine which translocates to
the outer side of plasma membrane during the early apop-
tosis [26]. To investigate the biochemical characterization
of apoptosis, we examined the externalization of phospha-
tidylserine (PS) in A549 cells by Annexin-V-FITC assay.
Annexin-V as a recombinant phosphatidylserine-binding
protein with a high affinity for externalized PS is used for
detection of early apoptosis [27]. PI was used for detection
of the late apoptosis and necrosis, while Annexin-V was
for the detection of the early and late apoptosis. Accord-
ingly, to evaluate whether A549 cells undergo apoptosis,
untreated and AMEAE-treated cells were stained with
Annexin-V and PI. Flow cytometry analysis of stained cells
can distinguish the cells into four categories, namely viable
(Annexin-V and PI negative), early apoptosis (Annexin-V
positive, PI negative), late apoptosis (Annexin-V and PI
positive) and necrotic (Annexin-V negative, PI positive)
cells. As illustrated in Figure 3, AMEAE treatment at dif-
ferent time periods (24, 48 and 72 h) resulted in a time-
dependent increment of early apoptotic and late apoptotic
Figure 2 Fluorescent micrographs of AO/PI-double-stained A549 cells. (A) Untreated A549 cells after 72 h depict healthy structures.
Early apoptosis features such as chromatin condensation and blebbing were observed after (B) 24, (C) 48 and 72 h (D) of treatment with AMEAE.
Late apoptosis was observed at the late stage of treatment (magnification: 200×). VC: Viable cells; CC: Chromatin condensation; BL: Blebbing of
the cell membrane; LA: Late apoptosis.
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after 72 h treatment.
AMEAE-induced G1 cell cycle arrest
Cancer is often considered as a disease of cell cycle de-
regulation. Cell size, extracellular growth signals and
DNA integrity are tightly regulated by multiple check-
points in cell cycle progression [28]. Cancer can origin-
ate from perturbation in the expression of positive or
negative regulators of cell cycle machinery leading to ab-
normal proliferation of cancer cells [29]. Thus, induction
of cell cycle arrest in cancer cells is considered to be one
of the crucial cancer treatment strategies. Phytochemi-
cals with the ability to modulate the cell cycle progres-
sion are gaining extensive attention because of the
supporting evidences of the concomitant involvement of
cell cycle suppression and apoptosis [30,31]. Thus, flow
cytometry analysis was performed to evaluate the effect
of AMEAE on the DNA content at various cell cycle
checkpoints of A549 cells by cell cycle phase distribution
(G0, G1, S, G2 and M) after treatment for 24, 48 and
72 h. As shown in Figure 4, there was a significant G0/
G1 phase arrest in a time-dependent manner demon-
strating that AMEAE arrested cell cycle progression atthe G0/G1 phase (Figure 4). Moreover, the increase in
the sub-G1 phase confirms the apoptosis findings.
ROS generation induced by AMEAE
Reactive oxygen species are produced as the result of
normal metabolism during the reduction of oxygen to
water. Oxidative stress due to increase in the level of
intracellular ROS leads to a variety of biochemical and
physiological lesions following to metabolic impairments
and cell death [32]. The stimulus of free radicals and
oxidative stress can trigger the mitochondrial initiated
events leading to the activation of intrinsic pathway [33].
Thus, there is an upsurge of interest in cancer studies to
use this major role for induction of apoptosis in cancer
cells. To investigate this association, the levels of intra-
cellular ROS in A549 cells treated with AMEAE was ex-
amined by flow cytometry analysis. In the present study, it
was found that AMEAE has noteworthy potential in the
induction of ROS generation in A549 cells as shown in
Figure 5. As a result of ROS generation, non-fluorescent
dihydroethidium (DHE) convert to the fluorescent dye of
ethidium, which can bind to DNA. A dose-dependent ele-
vation in ethidium fluorescence in the nucleus was de-
tected in treated A549 cells (Figure 5A). As shown in
Figure 3 Time-dependent induction of early and late apoptosis by AMEAE indicated the percentage of early apoptotic, late apoptotic
and necrotic cells after (B) 24, (C) 48 and (D) 72 h of treatment. (A) shows the cells treated with vehicle DMSO. The early and late apoptotic
events are depicted in the lower right and upper left quadrant of each panel. (E) Representative bar chart demonstrated significant elevation in a
number of early and late apoptotic cells after 48 h of treatment. The data represent the means ± SEM of three independent experiments. *p < 0.05
compared with the untreated group.
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trol untreated A549 cells. In contrast, treatment with
AMEAE (24 h) resulted in dose-dependent increase of
ROS production as shown by increased ethidium staining
in the nucleus (Figure 5A and B). However, pretreatment
of A549 cells with antioxidants, namely SOD and Cat sig-
nificantly increased the cell viability after 24 h compared
to the treatment with AMEAE alone (Figure 5C). The vi-
able cells was 62% and 78% by pretreatment with SOD
and Cat, respectively, compared with only about 43% by
treatment with AMEAE alone. This result supports the
close correlation between ROS burst and cytotoxic effect
of AMEAE, which suggests to be through activation of the
mitonchondrial initiated events.
Mitochondria-initiated events induced by AMEAE
During apoptosis, mitochondrial membrane potential is
frequently disrupted due to the formation of permeability
transition pores or the insertions of proapoptotic proteins,
such as, Bid or Bax in the mitochondrial membrane [34].
A variety of non-receptor mediated stimuli, including free
radicals, radiation, hypoxia and toxin can trigger the in-
trinsic signaling pathway [26]. The stimuli produce intra-
cellular signals that cause loss in MMP and the opening of
the mitochondrial permeability transition pore. These
changes in the inner mitochondrial membrane lead to the
release of various proteins from the intermembrane space
into the cytosol [35]. The main group of released proteinsconsists of serine protease HtrA2/Omi, cytochrome c and
Smac/DIABLO. Cytochrome c forms apoptosome through
binding to pro-caspase-9 as well as Apaf-1. Apoptosome
activates caspase-9 following with activation of caspase-3
[36,37].
It is well established that extensive ROS production
could result in the disruption of the plasma membrane
and mitochondrial damage, thus we further examined
the cell membrane permeability, MMP and cytochrome
c translocation [38]. To determine the function of mito-
chondria, we applied MMP fluorescent probe. As shown
in Figure 6A, untreated A549 cells were strongly stained
with red MMP dye, while treated A549 cells with AMEAE
were not markedly stained after 24 h. The dose-dependent
reduction in fluorescence intensities of MMP was associ-
ated with significant elevation in cell membrane perme-
ability which is shown by green fluorescence intensities in
Figure 6A. Furthermore, AMEAE significantly elevated
the translocation of cytochrome c from mitochondria to
cytosol in A549 cells after 24 h. In the treated A549
cells, the cyan fluorescence intensities of cytochrome c
dye (Figure 6A) were markedly increased presenting the
significant cytochrome c release from mitochondria.
The present findings demonstrated that treatment with
AMEAE revealed a concentration-dependent increase
in membrane permeability, attenuation of MMP, and
increase in cytochrome c in the cytosol when compared
to the control.
Figure 4 Flow cytometry analysis on cell cycle progression in A549 cells was carried out after incubation with AMEAE for (A) 0, (B) 24,
(C) 48 and (D) 72 h. (E) Representative bar chart demonstrated significant cell cycle arrest at the G1 phase. The data represent the means ± SEM
of three independent experiments. *p < 0.05 compared with the no-treatment group.
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Caspase activation with proteolytic effect at aspartic acid
residues are involved in an energy-dependent cascade of
molecular events towards apoptosis. To date, two major
groups of caspases have been identified to be involved in
apoptosis pathways, including executioners or effectors
(caspase-3, −6, −7) and initiators (caspase-2, −8, −9, −10)
[36]. Intrinsic and extrinsic pathways are activated by
their own initiator caspases, namely caspase-9 and −8,
respectively. The activation of initiator caspases will, inturn, lead to activation of executioner caspases. The
most critical of executioner caspases is considered to
be caspase-3 [26]. The execution pathway leads to cyto-
morphological changes, namely chromatin condensation,
cell shrinkage, formation of apoptotic bodies followed by
phagocytosis of the apoptotic cell [39]. In the present
study, we investigated whether AMEAE can activate the
caspases by examining A549 cells treated with different
concentrations for 24 h. The activity of both caspase-9
and caspase-3/7 were significantly elevated at 10, 20 and
Figure 5 Effect of AMEAE on ROS generation in A549 cells. (A) Representative images of A549 cells treated with medium alone and 10 μg/
mL of AMEAE for 24 h and stained with dihydroethidium and Hoechst 33342 dyes for 30 min. (B) Representative bar chart indicated dose-
dependent elevation in ROS formation in treated A549 cells. The level of ROS was significantly elevated at 5 to 40 μg/mL concentrations. (C)
Pretreatment of A549 cells with Cat and SOD for 1 h prior to the incubation with AMEAE caused a significant elevation in cell viability compared
to the treatment alone with AMEAE. The data represent the means ± SEM of three independent experiments. *p < 0.05 compared with the
untreated group.
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8 was only triggered at higher concentrations of 20 and
40 μg/mL, suggesting that AMEAE induced apoptosis
predominantly through mitochondrial-mediated intrin-
sic pathway (Figure 7). The western blot analysis of cas-
pases also showed that the protein expression of
cleaved caspase-3 and −9 was dose-dependently in-
creased upon treatment with AMEAE. The caspase-3
and −9 protein expressions were significantly up-regulated
at 10 to 40 μg/mL concentrations. These results suggest
the involvement of caspase cascade in AMEAE-mediated
apoptosis.
AMEAE induced upregulation of Bax and downregulation
of Bcl-2 at the gene expression level
The mitochondria-initiated events are tightly regulated
by the Bcl-2 family of proteins, including pro-apoptotic
and anti-apoptotic proteins. Progression and abortion of
apoptosis are governed by 25 genes in this family of pro-
teins [40]. The pro-apoptotic protein of Bax is involved
in the cytochrome c release from mitochondria to cytosol
via dimerization and translocation to the outer mitochon-
drial membrane [41]. Meanwhile, anti-apoptotic proteins
such as Bcl-2 suppress the translocation of cytochrome c
(5). The levels of both Bcl-2 and Bax mRNA expressionwere estimated by using quantitative PCR analysis. The re-
sults demonstrated that Bcl-2 expression decreased sig-
nificantly when A549 cells were treated with 20 and
40 μg/mL of AMEAE after 24 h as compared with the
control cells (Figure 8). The expression of the proapop-
totic Bax, however, increased significantly when treated
with 20 and 40 μg/mL of AMEAE (Figure 8). Therefore,
downregulation of Bcl-2 and upregulation of Bax upon
AMEAE treatment could lead to loss of MMP, which
facilitated cytochrome c release and activation of the
caspase cascade. These changes in the gene expression
of Bcl-2 and Bax confirmed the induction of apoptosis
via mitochondrial-mediated intrinsic pathway.
NF-κB translocation suppressed by AMEAE
The ability of nuclear factor-κB (NF-κB) to inhibit the
induction of apoptosis is considered to be involved in re-
sistance against cytotoxic therapies. A variety of stimuli
namely, anticancer agents and cellular stress can trigger
NF-κB activation, which has been linked to extrinsic sig-
naling pathway and inducible chemoresistance [42].
Thus, suppression of NF-κB translocation in conjunction
with chemotherapy can effectively elevate the effect of
cancer therapy [43]. In this study, the ArrayScan HSC
system was used to determine the role of AMEAE in the
Figure 7 Effect of AMEAE of caspases activation. (A) Relative luminescence dose-dependent activation of caspase-8, −9 and −3/7 in A549 cells
treated with various concentrations of AMEAE. Caspase-9 and −3/7 were significantly activated at 10 to 40 μg/mL concentrations. Meanwhile,
caspase-8 was activated at higher concentrations (20 and 40 μg/mL). (B) A549 cells were treated with the indicated concentrations of AMEAE for
24 h. The cell lysates were evaluated for levels of cleaved caspase-3 and −9. AMEAE induced the up-regulation of cleaved caspase-3 and −9.
(C) The quantitative analysis was expressed as a ratio to the expression of β-actin. The data represent the means ± SEM of three independent
experiments. *p < 0.05 compared with the untreated group.
B C D
Figure 6 Effect of AMEAE on cell membrane permeability, MMP and cytochrome c release. (A) Representative images of A549 cells treated
with medium alone and 10 μg/mL of AMEAE, and stained with MMP, cell membrane permeability, Hoechst 33342 and cytochrome c dyes.
AMEAE caused a marked elevation in cytochrome c leakage and cell membrane permeability, and a noteworthy decrease in MMP. Representative bar
charts indicating dose-dependent increased (B) cell permeability and reduced (C) MMP in treated A549 cells at 5 to 40 μg/mL concentrations. Meanwhile,
(D) cytochrome c was significantly released at 10 to 40 μg/mL concentrations. The data represent the means ± SEM of three independent experiments.
*p < 0.05 compared with the untreated group.
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A B
Figure 8 Effect of AMEAE on mRNA expression of A549 cells. Downregulation of (A) Bcl-2 and upregulation of (B) Bax at gene expression
level induced by AMEAE at 20 and 40 μg/mL concentrations after 24 h assessed by quantitative PCR analysis. The data represent the means ±
SEM of three independent experiments. *p < 0.05 compared with the untreated group.
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NF-κB fluorescence intensity was detected in the cyto-
plasm of A549 cells compared to the nuclei (Figure 9A).
After treatment with AMEAE, nuclear NF-κB fluores-
cent intensity was dose-dependently reduced (Figure 9B).
Stimulation of A549 cells by TNF-α resulted in a signifi-
cant elevation in NF-κB fluorescence intensity in the nu-
clei, while, A549 cells treated with AMEAE elicitedFigure 9 Effect of AMEAE on NF-κB activation. (A) Representative imag
to AMEAE (10 μg/mL) and then stimulated with TNF-α. (B) Representative
cells with AMEAE. The data represent the means ± SEM of three independsignificant suppressive effects on the activation of NF-κB
(Figure 9A and B), at 10, 20 and 40 μg/mL in a
concentration-dependent manner. The present findings
demonstrated that AMEAE treatment can effectively re-
duce the activation of NF-κB signaling pathway in A549
cells. We have shown here that the NF-kB translocation
can be suppressed by AMEAE, which suggests the involve-
ment of an NF-κB inhibition mechanism in apoptosis.es of the intracellular targets of stained A549 cells that were exposed
bar chart revealed the translocation of NF-κB nuclear in treated A549
ent experiments. *p < 0.05 compared with the untreated control group.
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In conclusion, the anticancer potential of ethyl acetate
extract of A. muricata leaves was supported by the evi-
dence provided in the present study, including lactate
dehydrogenase leakage, reactive oxygen species gener-
ation, loss in mitochondrial membrane potential, in-
crease in the level of cytochrome c, upregulation of Bax,
downregulation of Bcl-2 and activation of initiator and exe-
cutioner caspases. The antiproliferative effect of AMEAE
was accompanied by cell cycle arrest at G1 phase and sup-
pression of NF-κB translocation. The results confirmed the
involvement of intrinsic pathways in induced apoptosis.
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